Pyroptosis in glioma: Current management and future application
Immunological Reviews · 2024
DOI: 10.1111/imr.13294 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunological Reviews, 2024. Verfasst von Zeshang Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Bethune Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Pyroptosis, Glioma. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 167 Literaturangaben. Gefördert von: Subject Layout Project through the Natural Science Foundation funded by Department of Science and Technology, Jilin Province, China.
Abstract (Originalsprache)
Glioma, the predominant form of central nervous system (CNS) malignancies, presents a significant challenge due to its high prevalence and low 5‐year survival rate. The efficacy of current treatment methods is limited by the presence of the blood–brain barrier, the immunosuppressive microenvironment, and other factors. Immunotherapy has emerged as a promising approach, as it can overcome the blood–brain barrier. A tumor's immune privilege, which is induced by an immunosuppressive environment, constricts immunotherapy's clinical impact in glioma. Pyroptosis, a programmed cell death mechanism facilitated by gasdermins, plays a significant role in the management of glioma. Its ability to initiate and regulate tumor occurrence, progression, and metastasis is well‐established. However, it is crucial to note that uncontrolled or excessive cell death can result in tissue damage, acute inflammation, and cytokine release syndrome, thereby potentially promoting tumor advancement or recurrence. This paper aims to elucidate the molecular pathways involved in pyroptosis and subsequently discuss its induction in cancer therapy. In addition, the current treatment methods of glioma and the use of pyroptosis in these treatments are introduced. It is hoped to provide more ideas for the treatment of glioma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The First Bethune Hospital of Jilin University, Changchun, China.
- Department of Radiology, The First Bethune Hospital of Jilin University, Changchun, China.
- College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
ORCID-Profile: Xinyu Hong
Förderung
- Subject Layout Project through the Natural Science Foundation funded by Department of Science and Technology, Jilin Province, China
Zitieren
APA
Guo, Z., Su, Z., Wei, Y., Zhang, X., & Hong, X. (2024). Pyroptosis in glioma: Current management and future application. Immunological Reviews. https://doi.org/10.1111/imr.13294
Vancouver
Guo Z, Su Z, Wei Y, Zhang X, Hong X. Pyroptosis in glioma: Current management and future application. Immunological Reviews. 2024. doi:10.1111/imr.13294
BibTeX
@article{Guo2024,
author = {Guo, Zeshang and Su, Zhenjin and Wei, Ying and Zhang, Xingmei and Hong, Xinyu},
title = {Pyroptosis in glioma: Current management and future application},
journal = {Immunological Reviews},
year = {2024},
doi = {10.1111/imr.13294}
}
EUVIMED